Literature DB >> 18846336

Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.

Shaoxian Hu1, Wenze Xiao, Fang Kong, Dan Ke, Ruifang Qin, Min Su.   

Abstract

CD4(+)CD25(+) regulatory T cells (Tregs) and the expression of their molecular markers (GITR, Foxp3) in peripheral blood of the patients with systemic lupus erythematosus (SLE) were investigated in order to reveal the pathogenesis of SLE on the cellular and molecular levels. The level of Tregs in peripheral blood was detected by flow cytometry. The expression levels of GITR and Foxp3 mRNA in peripheral blood mononuclear cells (PBMCs) were assayed by reverse transcriptase-polymerase chain reaction (RT-PCR). The level of IL-6 in the plasma was measured by ELISA. Comparisons were made among 3 groups: the active SLE group, the inactive SLE group, and normal control group. The level of Tregs in the active SLE group and the inactive SLE group was significantly lower than in the normal control group (P<0.01). The level of Tregs in the active group was lower than in the inactive group with the difference being not significant (P>0.05). The level of Tregs in SLE patients was significantly negatively correlated with the disease active index in SLE (SLEDAI) (r=-0.81, P<0.01). The expression levels of GITR mRNA in PBMCs of the active SLE group and the inactive SLE group were significantly higher than in the normal control group (P<0.05), and those of Foxp3 mRNA in SLE patients of both active and inactive SLE groups were significantly lower than in the normal control group (P<0.05). There was no significant difference in the expression of GITR and Foxp3 mRNA between the active SLE group and inactive SLE group (P>0.05). The plasma levels of IL-6 in both the inactive SLE group and active SLE group were significantly higher than in the normal control group (P<0.01). The plasma level of IL-6 in the active SLE group was significantly increased as compared with that in the inactive SLE group (P<0.05), and the plasma level of IL-6 in SLE was significantly positively correlated with SLEDAI scores (r=0.58, P<0.01) and significantly negatively correlated with the ratio of CD4(+)CD25(+) cells/CD4(+) cells (r=-0.389, P<0.05). It was concluded that the levels of Tregs and Foxp3 mRNA in peripheral blood of SLE patients were decreased and the levels of GITR mRNA and plasma IL-6 were increased. The Tregs and their molecular markers GITR, Foxp3 as well as the plasma IL-6 might play an important role in the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846336     DOI: 10.1007/s11596-008-0513-y

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  14 in total

Review 1.  Development and function of CD25+CD4+ regulatory T cells.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

2.  Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

Authors:  Zoltán Fehérvári; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2004-11-01       Impact factor: 4.823

Review 3.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

Authors:  Jason D Fontenot; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

4.  The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

Authors:  Aysefa Doganci; Tatjana Eigenbrod; Norbert Krug; George T De Sanctis; Michael Hausding; Veit J Erpenbeck; El-Bdaoui Haddad; Hans A Lehr; Edgar Schmitt; Tobias Bopp; Karl-J Kallen; Udo Herz; Steffen Schmitt; Cornelia Luft; Olaf Hecht; Jens M Hohlfeld; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Stefan Rose-John; Harald Renz; Markus F Neurath; Peter R Galle; Susetta Finotto
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions.

Authors:  Suigui Wan; Changqing Xia; Laurence Morel
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

Review 6.  GITR/GITRL: more than an effector T cell co-stimulatory system.

Authors:  Giuseppe Nocentini; Simona Ronchetti; Salvatore Cuzzocrea; Carlo Riccardi
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

7.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

8.  Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

Authors:  Jyh-Hong Lee; Li-Chieh Wang; Yu-Tsan Lin; Yao-Hsu Yang; Dong-Tsamn Lin; Bor-Luen Chiang
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

9.  Quantification of regulatory T cells in patients with systemic lupus erythematosus.

Authors:  Jose C Crispin; Araceli Martínez; Jorge Alcocer-Varela
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

10.  Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.

Authors:  Chenthamarakshan Vasu; Bellur S Prabhakar; Mark J Holterman
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  8 in total

1.  IL-10 enhances promoter activity of ILT4 gene and up-regulates its expression in THP-1 cells.

Authors:  Xiaoli Xu; Ping Zou; Lijuan Chen; Guannan Jin; Hao Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

Review 2.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

Review 3.  Interferon alpha in systemic lupus erythematosus.

Authors:  Timothy B Niewold; Daniel N Clark; Rafah Salloum; Brian D Poole
Journal:  J Biomed Biotechnol       Date:  2010-06-29

4.  Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus.

Authors:  Nan Xiang; Xiang-Pei Li; Xiao-Mei Li; Guo-Sheng Wang; Jin-Hui Tao; Hai-Feng Pan; Xuan Fang; Qian Ma; Ning Yu
Journal:  Clin Exp Med       Date:  2013-11-13       Impact factor: 3.984

5.  Effects of royal jelly supplementation on regulatory T cells in children with SLE.

Authors:  Asmaa M Zahran; Khalid I Elsayh; Khaled Saad; Esraa M A Eloseily; Naglaa S Osman; Mohamd A Alblihed; Gamal Badr; Mohamed H Mahmoud
Journal:  Food Nutr Res       Date:  2016-11-24       Impact factor: 3.894

6.  The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.

Authors:  Wenli Li; Chuiwen Deng; Hanbo Yang; Guochun Wang
Journal:  Front Immunol       Date:  2019-02-18       Impact factor: 7.561

7.  Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients.

Authors:  Sonia Garcia-Rodriguez; Jose-Luis Callejas-Rubio; Norberto Ortego-Centeno; Esther Zumaquero; Raquel Ríos-Fernandez; Salvador Arias-Santiago; Pilar Navarro; Jaime Sancho; Mercedes Zubiaur
Journal:  Mediators Inflamm       Date:  2012-10-18       Impact factor: 4.711

Review 8.  The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis.

Authors:  Sheng-Xiao Zhang; Xiao-Wen Ma; Yu-Feng Li; Na-Ling Lai; Ze-Hao Huang; Kai Fan; Cai-Hong Wang; Xiao-Feng Li
Journal:  J Immunol Res       Date:  2018-09-03       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.